Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy

INTRODUCTION: Unstable angina (UA), referred to as acute coronary syndrome (ACS), causes unexpected chest pain. Xueshuantong injection (lyophilised) (XST) is a traditional Chinese herbal injection having the potential to treat ACS. However, no clinical trial has been performed in this field. This cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Wenjie, Liao, Huili, Huang, Xi, Liu, Qingqing, Tang, Yaqing, Lu, Liming, Liu, Jianhong, Yuan, Tianhui, Ling, Yan, Hong, Yu, Duan, Jiao, Lin, Weiji, Xian, Shaoxiang, Yang, Zhongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451462/
https://www.ncbi.nlm.nih.gov/pubmed/32847917
http://dx.doi.org/10.1136/bmjopen-2020-038074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451462/
https://www.ncbi.nlm.nih.gov/pubmed/32847917
http://dx.doi.org/10.1136/bmjopen-2020-038074

Ejemplares similares